Viewing Study NCT00194532



Ignite Creation Date: 2024-05-05 @ 11:58 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00194532
Status: COMPLETED
Last Update Posted: 2014-06-10
First Post: 2005-09-13

Brief Title: Cefpodoxime vs Ciprofloxacin for Acute Cystitis
Sponsor: University of Washington
Organization: University of Washington

Study Overview

Official Title: Cefpodoxime vs Ciprofloxacin for Acute Cystitis
Status: COMPLETED
Status Verified Date: 2014-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Urinary tract infection UTI is a very common problem in young healthy women afflicting approximately one-half of women by their late 20s One of the most common antibiotics used to treat UTIs is ciprofloxacin usually for a total of three days However increasing resistance to this antibiotic has raised concerns about its overuse for cystitis and generated interest in alternative agents An alternative antibiotic which is approved for use in UTIs is cefpodoxime However there are few studies evaluating the efficacy and tolerance of this compound when given in a 3-day regimen as is commonly used for treatment of UTI The major purpose of this study is to assess the efficacy and tolerance of a 3-day regimen of cefpodoxime versus ciprofloxacin for treatment of acute uncomplicated cystitis
Detailed Description: Procedures subjects will undergo once they have read and signed the consent are

Questions about their medical and sexual history and current symptoms of UTI They will be asked to provide a urine and peri-urethral sample and then are randomly assigned to one of the two treatment groupsThey will be given a sheet to record symptoms at home They will be asked to return to the clinic in 5-9 and 28-30 days after completing antibiotic therapyFollow-up questions will be asked and urine and peri-urethral will be self collected at each visit

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None